The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Toxoplasmosis Diagnostic Testing Market Research Report 2025
Synopsis
The global Toxoplasmosis Diagnostic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Toxoplasmosis Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Toxoplasmosis Diagnostic Testing.
Report Scope
The Toxoplasmosis Diagnostic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Toxoplasmosis Diagnostic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Toxoplasmosis Diagnostic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Thermo Fisher Scientific
Bio-Rad
Danaher
Biomerica
Biotest
GenBio
Segment by Type
Indirect Immune Fluorescent Test (IFAT)
Modified Agglutination Test (MAT)
Enzyme-Linked Immunosorbent Assay (ELISA)
Immunoglobulin Tests
Segment by Application
Hospitals
Clinics
Diagnostic Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Toxoplasmosis Diagnostic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Toxoplasmosis Diagnostic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Toxoplasmosis Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Toxoplasmosis Diagnostic Testing.
Report Scope
The Toxoplasmosis Diagnostic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Toxoplasmosis Diagnostic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Toxoplasmosis Diagnostic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Thermo Fisher Scientific
Bio-Rad
Danaher
Biomerica
Biotest
GenBio
Segment by Type
Indirect Immune Fluorescent Test (IFAT)
Modified Agglutination Test (MAT)
Enzyme-Linked Immunosorbent Assay (ELISA)
Immunoglobulin Tests
Segment by Application
Hospitals
Clinics
Diagnostic Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Toxoplasmosis Diagnostic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Toxoplasmosis Diagnostic Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Indirect Immune Fluorescent Test (IFAT)
1.2.3 Modified Agglutination Test (MAT)
1.2.4 Enzyme-Linked Immunosorbent Assay (ELISA)
1.2.5 Immunoglobulin Tests
1.3 Market by Application
1.3.1 Global Toxoplasmosis Diagnostic Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Toxoplasmosis Diagnostic Testing Market Perspective (2019-2030)
2.2 Toxoplasmosis Diagnostic Testing Growth Trends by Region
2.2.1 Global Toxoplasmosis Diagnostic Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Toxoplasmosis Diagnostic Testing Historic Market Size by Region (2019-2024)
2.2.3 Toxoplasmosis Diagnostic Testing Forecasted Market Size by Region (2025-2030)
2.3 Toxoplasmosis Diagnostic Testing Market Dynamics
2.3.1 Toxoplasmosis Diagnostic Testing Industry Trends
2.3.2 Toxoplasmosis Diagnostic Testing Market Drivers
2.3.3 Toxoplasmosis Diagnostic Testing Market Challenges
2.3.4 Toxoplasmosis Diagnostic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Toxoplasmosis Diagnostic Testing Players by Revenue
3.1.1 Global Top Toxoplasmosis Diagnostic Testing Players by Revenue (2019-2024)
3.1.2 Global Toxoplasmosis Diagnostic Testing Revenue Market Share by Players (2019-2024)
3.2 Global Toxoplasmosis Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Toxoplasmosis Diagnostic Testing Revenue
3.4 Global Toxoplasmosis Diagnostic Testing Market Concentration Ratio
3.4.1 Global Toxoplasmosis Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Toxoplasmosis Diagnostic Testing Revenue in 2023
3.5 Toxoplasmosis Diagnostic Testing Key Players Head office and Area Served
3.6 Key Players Toxoplasmosis Diagnostic Testing Product Solution and Service
3.7 Date of Enter into Toxoplasmosis Diagnostic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Toxoplasmosis Diagnostic Testing Breakdown Data by Type
4.1 Global Toxoplasmosis Diagnostic Testing Historic Market Size by Type (2019-2024)
4.2 Global Toxoplasmosis Diagnostic Testing Forecasted Market Size by Type (2025-2030)
5 Toxoplasmosis Diagnostic Testing Breakdown Data by Application
5.1 Global Toxoplasmosis Diagnostic Testing Historic Market Size by Application (2019-2024)
5.2 Global Toxoplasmosis Diagnostic Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Toxoplasmosis Diagnostic Testing Market Size (2019-2030)
6.2 North America Toxoplasmosis Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Toxoplasmosis Diagnostic Testing Market Size by Country (2019-2024)
6.4 North America Toxoplasmosis Diagnostic Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Toxoplasmosis Diagnostic Testing Market Size (2019-2030)
7.2 Europe Toxoplasmosis Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Toxoplasmosis Diagnostic Testing Market Size by Country (2019-2024)
7.4 Europe Toxoplasmosis Diagnostic Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size (2019-2030)
8.2 Asia-Pacific Toxoplasmosis Diagnostic Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Toxoplasmosis Diagnostic Testing Market Size (2019-2030)
9.2 Latin America Toxoplasmosis Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Toxoplasmosis Diagnostic Testing Market Size by Country (2019-2024)
9.4 Latin America Toxoplasmosis Diagnostic Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size (2019-2030)
10.2 Middle East & Africa Toxoplasmosis Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Toxoplasmosis Diagnostic Testing Introduction
11.1.4 Abbott Revenue in Toxoplasmosis Diagnostic Testing Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Toxoplasmosis Diagnostic Testing Introduction
11.2.4 Thermo Fisher Scientific Revenue in Toxoplasmosis Diagnostic Testing Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Bio-Rad
11.3.1 Bio-Rad Company Detail
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad Toxoplasmosis Diagnostic Testing Introduction
11.3.4 Bio-Rad Revenue in Toxoplasmosis Diagnostic Testing Business (2019-2024)
11.3.5 Bio-Rad Recent Development
11.4 Danaher
11.4.1 Danaher Company Detail
11.4.2 Danaher Business Overview
11.4.3 Danaher Toxoplasmosis Diagnostic Testing Introduction
11.4.4 Danaher Revenue in Toxoplasmosis Diagnostic Testing Business (2019-2024)
11.4.5 Danaher Recent Development
11.5 Biomerica
11.5.1 Biomerica Company Detail
11.5.2 Biomerica Business Overview
11.5.3 Biomerica Toxoplasmosis Diagnostic Testing Introduction
11.5.4 Biomerica Revenue in Toxoplasmosis Diagnostic Testing Business (2019-2024)
11.5.5 Biomerica Recent Development
11.6 Biotest
11.6.1 Biotest Company Detail
11.6.2 Biotest Business Overview
11.6.3 Biotest Toxoplasmosis Diagnostic Testing Introduction
11.6.4 Biotest Revenue in Toxoplasmosis Diagnostic Testing Business (2019-2024)
11.6.5 Biotest Recent Development
11.7 GenBio
11.7.1 GenBio Company Detail
11.7.2 GenBio Business Overview
11.7.3 GenBio Toxoplasmosis Diagnostic Testing Introduction
11.7.4 GenBio Revenue in Toxoplasmosis Diagnostic Testing Business (2019-2024)
11.7.5 GenBio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Toxoplasmosis Diagnostic Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Indirect Immune Fluorescent Test (IFAT)
Table 3. Key Players of Modified Agglutination Test (MAT)
Table 4. Key Players of Enzyme-Linked Immunosorbent Assay (ELISA)
Table 5. Key Players of Immunoglobulin Tests
Table 6. Global Toxoplasmosis Diagnostic Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Toxoplasmosis Diagnostic Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Toxoplasmosis Diagnostic Testing Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Toxoplasmosis Diagnostic Testing Market Share by Region (2019-2024)
Table 10. Global Toxoplasmosis Diagnostic Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Toxoplasmosis Diagnostic Testing Market Share by Region (2025-2030)
Table 12. Toxoplasmosis Diagnostic Testing Market Trends
Table 13. Toxoplasmosis Diagnostic Testing Market Drivers
Table 14. Toxoplasmosis Diagnostic Testing Market Challenges
Table 15. Toxoplasmosis Diagnostic Testing Market Restraints
Table 16. Global Toxoplasmosis Diagnostic Testing Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Toxoplasmosis Diagnostic Testing Market Share by Players (2019-2024)
Table 18. Global Top Toxoplasmosis Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Toxoplasmosis Diagnostic Testing as of 2023)
Table 19. Ranking of Global Top Toxoplasmosis Diagnostic Testing Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Toxoplasmosis Diagnostic Testing Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Toxoplasmosis Diagnostic Testing Product Solution and Service
Table 23. Date of Enter into Toxoplasmosis Diagnostic Testing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Toxoplasmosis Diagnostic Testing Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Toxoplasmosis Diagnostic Testing Revenue Market Share by Type (2019-2024)
Table 27. Global Toxoplasmosis Diagnostic Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Toxoplasmosis Diagnostic Testing Revenue Market Share by Type (2025-2030)
Table 29. Global Toxoplasmosis Diagnostic Testing Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Toxoplasmosis Diagnostic Testing Revenue Market Share by Application (2019-2024)
Table 31. Global Toxoplasmosis Diagnostic Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Toxoplasmosis Diagnostic Testing Revenue Market Share by Application (2025-2030)
Table 33. North America Toxoplasmosis Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Toxoplasmosis Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Toxoplasmosis Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Toxoplasmosis Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Toxoplasmosis Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Toxoplasmosis Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Toxoplasmosis Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Toxoplasmosis Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Toxoplasmosis Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 48. Abbott Company Detail
Table 49. Abbott Business Overview
Table 50. Abbott Toxoplasmosis Diagnostic Testing Product
Table 51. Abbott Revenue in Toxoplasmosis Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 52. Abbott Recent Development
Table 53. Thermo Fisher Scientific Company Detail
Table 54. Thermo Fisher Scientific Business Overview
Table 55. Thermo Fisher Scientific Toxoplasmosis Diagnostic Testing Product
Table 56. Thermo Fisher Scientific Revenue in Toxoplasmosis Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 57. Thermo Fisher Scientific Recent Development
Table 58. Bio-Rad Company Detail
Table 59. Bio-Rad Business Overview
Table 60. Bio-Rad Toxoplasmosis Diagnostic Testing Product
Table 61. Bio-Rad Revenue in Toxoplasmosis Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 62. Bio-Rad Recent Development
Table 63. Danaher Company Detail
Table 64. Danaher Business Overview
Table 65. Danaher Toxoplasmosis Diagnostic Testing Product
Table 66. Danaher Revenue in Toxoplasmosis Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 67. Danaher Recent Development
Table 68. Biomerica Company Detail
Table 69. Biomerica Business Overview
Table 70. Biomerica Toxoplasmosis Diagnostic Testing Product
Table 71. Biomerica Revenue in Toxoplasmosis Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 72. Biomerica Recent Development
Table 73. Biotest Company Detail
Table 74. Biotest Business Overview
Table 75. Biotest Toxoplasmosis Diagnostic Testing Product
Table 76. Biotest Revenue in Toxoplasmosis Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 77. Biotest Recent Development
Table 78. GenBio Company Detail
Table 79. GenBio Business Overview
Table 80. GenBio Toxoplasmosis Diagnostic Testing Product
Table 81. GenBio Revenue in Toxoplasmosis Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 82. GenBio Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Toxoplasmosis Diagnostic Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Toxoplasmosis Diagnostic Testing Market Share by Type: 2023 VS 2030
Figure 3. Indirect Immune Fluorescent Test (IFAT) Features
Figure 4. Modified Agglutination Test (MAT) Features
Figure 5. Enzyme-Linked Immunosorbent Assay (ELISA) Features
Figure 6. Immunoglobulin Tests Features
Figure 7. Global Toxoplasmosis Diagnostic Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Toxoplasmosis Diagnostic Testing Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Diagnostic Laboratories Case Studies
Figure 12. Others Case Studies
Figure 13. Toxoplasmosis Diagnostic Testing Report Years Considered
Figure 14. Global Toxoplasmosis Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Toxoplasmosis Diagnostic Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Toxoplasmosis Diagnostic Testing Market Share by Region: 2023 VS 2030
Figure 17. Global Toxoplasmosis Diagnostic Testing Market Share by Players in 2023
Figure 18. Global Top Toxoplasmosis Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Toxoplasmosis Diagnostic Testing as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Toxoplasmosis Diagnostic Testing Revenue in 2023
Figure 20. North America Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Toxoplasmosis Diagnostic Testing Market Share by Country (2019-2030)
Figure 22. United States Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Toxoplasmosis Diagnostic Testing Market Share by Country (2019-2030)
Figure 26. Germany Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Toxoplasmosis Diagnostic Testing Market Share by Region (2019-2030)
Figure 34. China Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Toxoplasmosis Diagnostic Testing Market Share by Country (2019-2030)
Figure 42. Mexico Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Toxoplasmosis Diagnostic Testing Market Share by Country (2019-2030)
Figure 46. Turkey Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Abbott Revenue Growth Rate in Toxoplasmosis Diagnostic Testing Business (2019-2024)
Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Toxoplasmosis Diagnostic Testing Business (2019-2024)
Figure 50. Bio-Rad Revenue Growth Rate in Toxoplasmosis Diagnostic Testing Business (2019-2024)
Figure 51. Danaher Revenue Growth Rate in Toxoplasmosis Diagnostic Testing Business (2019-2024)
Figure 52. Biomerica Revenue Growth Rate in Toxoplasmosis Diagnostic Testing Business (2019-2024)
Figure 53. Biotest Revenue Growth Rate in Toxoplasmosis Diagnostic Testing Business (2019-2024)
Figure 54. GenBio Revenue Growth Rate in Toxoplasmosis Diagnostic Testing Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
